Skip to main content
SpringerLink
Log in

Risk Stratification in Acute Coronary Syndromes

  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

Accurate and readily available systems for risk stratification and a wide array of antithrombotic agents, on top of classical anti-ischemic drugs, provide the noninvasive cardiologist admitting the patient in the CCU with an effective and reliable armamentarium for the safe management of most patients with ACS. From the interventionalist’s perspective, the immediate knowledge of the coronary anatomy yields the most valuable information to address the most appropriate treatment. The sooner angiography is performed the higher the benefit for patients at moderate to high risk, but if performed by expert teams and with the correct use of modern drugs and devices, the invasive approach has the potential to reduce costs and length of hospital stay also in low-risk patients. Although still some reluctance remains to equalize treatment strategies for patients with STEMI to those with NSTEMI, such differences will likely disappear in the near future with upcoming new evidence. Cardiac surgery may represent a life-saving alternative for patients presenting with NSTEMI evolving in cardiogenic shock or with mechanical complications, or in patients unsuitable for PCI or with failed PCI attempts. In stabilized conditions after the treatment of the culprit lesion, patients with severe multivessel disease may benefit from cardiac surgery to complete myocardial revascularization. Indications for CABG in this setting should be evaluated in the context of a local “heart team” or through prespecified protocols in centers without cardiac surgery on site.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Avezum, A., Makdisse, M., Spencer, F., GRACE Investigators, et al. (2005). Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). American Heart Journal, 149, 67–73.

    Article  PubMed  Google Scholar 

  2. Fox, K. A., Eagle, K. A., Gore, J. M., et al. (2010). The global registry of acute coronary events, 1999 to 2009—Grace. Heart, 96, 1095–1101.

    Article  PubMed  CAS  Google Scholar 

  3. Terkelsen, C. J., Lassen, J. F., Norgaard, B. L., et al. (2005). Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. European Heart Journal, 26, 18–26.

    Article  PubMed  Google Scholar 

  4. Anderson, J. L., Adams, C. D., Antman, E. M., 2011 WRITING GROUP MEMBERS, ACCF/AHA TASK FORCE MEMBERS, et al. (2011). 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 123, e426–e579.

    Article  PubMed  Google Scholar 

  5. Thygesen, K., Alpert, J. S., White, H. D., et al. (2007). Universal definition of myocardial infarction. Circulation, 116, 2634–2653.

    Article  PubMed  Google Scholar 

  6. De Araujo Goncalves, P., Ferreira, J., Aguiar, C., & Seabra-Gomes, R. (2005). TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J, 26, 865–872.

    Article  PubMed  Google Scholar 

  7. Eggers, K. M., Kempf, T., Venge, P., Wallentin, L., Wollert, K. C., & Lindahl, B. (2010). Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers. American Heart Journal, 160, 88–94.

    Article  PubMed  Google Scholar 

  8. Antman, E. M., Cohen, M., Bernink, P. J., et al. (2000). The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA: The Journal of the American Medical Association, 284, 835–842.

    Article  CAS  Google Scholar 

  9. Antman, E. M., McCabe, C. H., Gurfinkel, E. P., et al. (1999). Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial. Circulation, 100, 1593–1601.

    PubMed  CAS  Google Scholar 

  10. Cohen, M., Demers, C., Gurfinkel, E. P., et al. (1997). A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. The New England Journal of Medicine, 337, 447–452.

    Article  PubMed  CAS  Google Scholar 

  11. Fox, K. A., Dabbous, O. H., Goldberg, R. J., et al. (2006). Prediction of risk of death and myocardial infarction in the 6 months after presentation with acute coronary syndrome: Prospective multinational observational study (GRACE). BMJ, 333, 1091.

    Article  PubMed  Google Scholar 

  12. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators. (1996). A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. The New England Journal of Medicine, 335, 775–782.

    Article  Google Scholar 

  13. Hamm, C. W., Bassand, J. P., Agewall, S., et al. (2011). ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). The European Heart Journal (in press)

  14. Peterson, J. G., Topol, E. J., Roe, M. T., et al. (2001). Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. The American Journal of Cardiology, 87, 532–536.

    Article  PubMed  CAS  Google Scholar 

  15. Eikelboom, J. W., Mehta, S. R., Anand, S. S., Xie, C., Fox, K. A., & Yusuf, S. (2006). Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation, 114, 774–782.

    Article  PubMed  Google Scholar 

  16. Stone, G. W., Ware, J. H., Bertrand, M. E., ACUITY Investigators, et al. (2007). Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: One-year results from the ACUITY trial. JAMA: The Journal of the American Medical Association, 298, 2497–2506.

    Article  CAS  Google Scholar 

  17. Mehran, R., Lansky, A. J., Witzenbichler, B., HORIZONS-AMI Trial Investigators, et al. (2009). Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet, 374, 1149–1159.

    Article  PubMed  Google Scholar 

  18. Subherwal, S., Bach, R. G., Chen, A. Y., et al. (2009). Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation, 119, 1873–1882.

    Article  PubMed  Google Scholar 

  19. Jolly, S. S., Yusuf, S., Cairns, J., et al. (2011). Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): A randomized, parallel group, multicenter trial. Lancet, 377(9775), 1409–1420.

    Article  PubMed  Google Scholar 

  20. Rodrigues, F. B., Bruetto, R. G., Torres, U. S., Otaviano, A. P., Zanetta, D. M., & Burdmann, E. A. (2010). Effect of kidney disease on acute coronary syndrome. Clinical Journal of the American Society of Nephrology, 8, 1530–1536.

    Article  Google Scholar 

  21. Pitsavos, C., Kurlaba, G., Demosthenes, B., et al. (2007). Association of creatinine clearance and in-hospital mortality in patients with acute coronary syndromes—The GREECS Study. Circulation Journal, 71, 9–14.

    Article  PubMed  CAS  Google Scholar 

  22. Reichlin, T., Hochholzer, W., Bassetti, S., et al. (2009). Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. The New England Journal of Medicine, 361, 858–867.

    Article  PubMed  CAS  Google Scholar 

  23. Lindahl, B., Toss, H., Siegbahn, A., Venge, P., & Wallentin, L. (2000). Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. The New England Journal of Medicine, 343, 1139–1147.

    Article  PubMed  CAS  Google Scholar 

  24. Correia, L. C., & Esteves, J. P. (2011). C-reactive protein and outcomes in acute coronary syndromes: A systematic review and meta-analysis. Arquivos Brasileiros de Cardiologia, 97, 76–85.

    Article  PubMed  Google Scholar 

  25. Scirica, B. M., Sabatine, M. S., Jarolim, P., et al. (2011). Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: Observations from the MERLIN-TIMI 36 trial. European Heart Journal, 32, 697–705.

    Article  PubMed  CAS  Google Scholar 

  26. Tousoulis, D., Androulakis, E., Papageorgiou, N., et al. (2010). Trends from atherosclerosis to acute coronary syndromes: The role of soluble CD40 ligand. Cardiovascular Medicine, 20, 153–164.

    Article  CAS  Google Scholar 

  27. O’Donoghue, M., Boden, W. E., Braunwald, E., et al. (2008). Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: A meta-analysis. JAMA: The Journal of the American Medical Association, 300, 71–80.

    Article  Google Scholar 

  28. Fox, K. A., Clayton, T. C., Damman, P., et al. (2010). Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. Journal of the American College of Cardiology, 55, 2435–2445.

    Article  PubMed  Google Scholar 

  29. Silva, J. A., Escobar, A., Collins, T. J., Ramee, S. R., & White, C. J. (1995). Unstable angina: A comparison of angioscopic findings between diabetic and nondiabetic patients. Circulation, 92, 1731–1736.

    PubMed  CAS  Google Scholar 

  30. Berger, J. S., Elliott, L., Gallup, D., et al. (2009). Sex differences in mortality following acute coronary syndromes. JAMA: The Journal of the American Medical Association, 302, 874–882.

    Article  CAS  Google Scholar 

  31. Wiviott, S. D., Braunwald, E., Angiolillo, D. J., et al. (2008). Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel—Thrombolysis in Myocardial Infarction 38. Circulation, 118, 1626–1636.

    Article  PubMed  CAS  Google Scholar 

  32. Held, C., Asenblad, N., Bassand, J. P., et al. (2011). Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery results from the PLATO (Platelet Inhibition and Patient Outcomes) Trial. Journal of the American College of Cardiology, 57, 672–684.

    Article  PubMed  CAS  Google Scholar 

  33. Yusuf, S., Mehta, S. R., Chrolavicius, S., et al. (2006). Comparison of fondaparinux and enoxaparin in acute coronary syndromes. The New England Journal of Medicine, 354, 1464–1476.

    Article  PubMed  CAS  Google Scholar 

  34. Sami, S., & Willerson, J. T. (2010). Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 1). Texas Heart Institute Journal, 37, 141–148.

    PubMed  Google Scholar 

  35. Mega, J. L., Close, S. L., Wiviott, S. D., et al. (2009). Cytochrome p-450 polymorphisms and response to clopidogrel. The New England Journal of Medicine, 360, 354–362.

    Article  PubMed  CAS  Google Scholar 

  36. Collet, J. P., Hulot, J. S., Pena, A., et al. (2009). Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: A cohort study. Lancet, 373, 309–317.

    Article  PubMed  CAS  Google Scholar 

  37. Damani, S. B., & Topol, E. J. (2010). The case for routine genotyping in dual-antiplatelet therapy. Journal of the American College of Cardiology, 56, 109–111.

    Article  PubMed  Google Scholar 

  38. Stone, G. W., Rizvi, A., Sudhir, K., SPIRIT IV Investigators, et al. (2011). Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. Journal of the American College of Cardiology, 58, 19–25.

    Article  PubMed  Google Scholar 

  39. Silber, S., Windecker, S., Vranckx, P., Serruys, P. W., & RESOLUTE All Comers investigators. (2011). Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial. Lancet, 377, 1241–1247.

    Article  PubMed  CAS  Google Scholar 

  40. Wijns, W., Kolh, P., Danchin, N., et al. (2010). Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 31, 2501–2555.

    Article  PubMed  Google Scholar 

  41. Serruys, P. W., Morice, M. C., Kappetein, A. P., SYNTAX Investigators, et al. (2009). Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. The New England Journal of Medicine, 360, 961–972.

    Article  PubMed  CAS  Google Scholar 

  42. Serruys PW. Four years data from the SYNTAX Trial. www.theheart.org. Accessed 18 October 2011.

  43. Voisine, P., Mathieu, P., Doyle, D., et al. (2006). Influence of time elapsed between myocardial infarction and coronary artery bypass grafting surgery on operative mortality. European Journal of Cardio-Thoracic Surgery, 29, 319–323.

    Article  PubMed  Google Scholar 

  44. Lee, D. C., Oz, M. C., Weinberg, A. D., Lin, S. X., & Ting, W. (2001). Optimal timing of revascularization: Transmural versus nontransmural acute myocardial infarction. The Annals of Thoracic Surgery, 71, 1197–1204.

    Article  PubMed  CAS  Google Scholar 

  45. Kamohara, K., Yoshikai, M., Yunoki, J., et al. (2006). Surgical revascularization for acute coronary syndrome: Comparative surgical and long-term results. The Japanese Journal of Thoracic and Cardiovascular Surgery, 54, 95–102.

    Article  PubMed  Google Scholar 

  46. Weiss, E. S., Chang, D. D., Joyce, D. L., Nwakanma, L. U., & Yuh, D. D. (2008). Optimal timing of coronary artery bypass after acute myocardial infarction: A review of California discharge data. The Journal of Thoracic and Cardiovascular Surgery, 135, 503–511.

    Article  PubMed  Google Scholar 

  47. Brown, C., Joshi, B., Faraday, N., et al. (2011). Emergency cardiac surgery in patients with acute coronary syndromes: A review of the evidence and perioperative implications of medical and mechanical therapeutics. Anesthesia and Analgesia, 112, 777–799.

    Article  PubMed  Google Scholar 

  48. Dacey, L. J., Munoz, J. J., Baribeau, Y. R., et al. (1998). Reexploration for hemorrhage following coronary artery bypass grafting: Incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Archives of Surgery, 133, 442–447.

    Article  PubMed  CAS  Google Scholar 

  49. Goodnough, L. T., Shander, A., & Brecher, M. E. (2003). Transfusion medicine: Looking to the future. Lancet, 361, 161–169.

    Article  PubMed  Google Scholar 

  50. McDonald, S. B., Renna, M., Spitznagel, E. L., et al. (2005). Preoperative use of enoxaparin increases the risk of postoperative bleeding and re-exploration in cardiac surgery patients. Journal of Cardiothoracic and Vascular Anesthesia, 19, 4–10.

    Article  PubMed  CAS  Google Scholar 

  51. Ascione, R., Ghosh, A., Rogers, C. A., Cohen, A., Monk, C., & Angelini, G. D. (2005). In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: A word of caution. The Annals of Thoracic Surgery, 79, 1210–1216.

    Article  PubMed  Google Scholar 

  52. Chu, M. W., Wilson, S. R., Novick, R. J., Stitt, L. W., & Quantz, M. A. (2004). Does clopidogrel increase blood loss following coronary artery bypass surgery? The Annals of Thoracic Surgery, 78, 1536–1541.

    Article  PubMed  Google Scholar 

  53. Hongo, R. H., Ley, J., Dick, S. E., & Yee, R. R. (2002). The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. Journal of the American College of Cardiology, 40, 231–237.

    Article  PubMed  CAS  Google Scholar 

  54. Kapetanakis, E. I., Medlam, D. A., Boyce, S. W., et al. (2005). Clopidogrel administration prior to coronary artery bypass grafting surgery: The cardiologist’s panacea or the surgeon’s headache? European Heart Journal, 26, 576–583.

    Article  PubMed  CAS  Google Scholar 

  55. Ben-Gal, Y., Stone, G. W., Smith, C. R., et al. (2011). On-pump versus off-pump surgical revascularization in patients with acute coronary syndromes: Analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial. The Journal of Thoracic and Cardiovascular Surgery, 142, e33–e39.

    Article  PubMed  Google Scholar 

  56. Comas, G. M., Esrig, B. C., & Oz, M. C. (2007). Surgery for myocardial salvage in acute myocardial infarction and acute coronary syndromes. Heart Failure Clinics, 3, 181–210.

    Article  PubMed  Google Scholar 

  57. Dang, N. C., Topkara, V. K., Leacche, M., et al. (2005). Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study. The Journal of Thoracic and Cardiovascular Surgery, 130, 693–698.

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

None declared.

Author information

Authors and Affiliations

  1. Department of Medicine, University of Verona, Verona, Italy

    Gabriele Pesarini, Francesco Santini, Giulia Geremia, Carlo Zivelonghi & Flavio Ribichini

  2. Interventional Cardiovascular Unit, University of Verona, Pzle. A Stefani 1, 37126, Verona, Italy

    Flavio Ribichini

Authors
  1. Gabriele Pesarini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesco Santini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giulia Geremia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carlo Zivelonghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Flavio Ribichini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Flavio Ribichini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pesarini, G., Santini, F., Geremia, G. et al. Risk Stratification in Acute Coronary Syndromes. J. of Cardiovasc. Trans. Res. 5, 1–10 (2012). https://doi.org/10.1007/s12265-011-9337-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-011-9337-4

Keywords

Search

Navigation